Author Archives: Pharm Exec

Positive Results for Ebola Vaccine

Immunovaccine Inc., a clinical stage vaccine company, announced on Aug. 25 positive results for a vaccine formulated in its DepoVax technology in an Ebola virus challenge study performed by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH. In a preliminary study, four vaccinated cynomolgus macaque, which are particularly sensitive to the Ebola […]
Posted in Global, healthcare | Tagged , | Leave a comment

China Closes In On US As Biggest Healthcare Market

China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU). EIU’s China Healthy Province Index (CHPI) provides a detailed healthcare profile of each of China’s 31 provinces,ranking provinces […]
Posted in Emerging Markets, Global, healthcare | Tagged , , , , , | Leave a comment

ADHD Market to Reach Nearly $10 Billion by 2020

The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to GBI Research. The company’s new report states that the increase — which represents a Compound Annual Growth Rate (CAGR) of 5.3% and relates to […]
Posted in Global, Strategy | Tagged , , , | Leave a comment

USP Analytical Research Award Winners 2014

An international group of three scientists are the recipients of United States Pharmacopeial Convention’s 2014–2015 Global Fellowship Awards, aimed at advancing research involving quality standards for medicines. The recipients’ research will involve analytical tools useful in researching the safety of biopharmaceutical drugs, the detection of substandard drugs in the developing world, and the quality of dry […]
Posted in Emerging Markets, Safety | Tagged , , | Leave a comment

New Products Will Force 'Radical Shift' in Hemophilia Drug Market

The hemophilia treatment landscape is to undergo a radical shift away from established short-acting therapies, beginning with the launch of Biogen Idec’s long-acting rFVIII and rFIX products this year, according to research and consulting firm GlobalData. The GlobalData report states that the patient shares of currently marketed short-acting recombinant products will erode considerably by 2022 […]
Posted in Global | Tagged , | Leave a comment
  • Categories

  • Meta